CytoSorbents to Present at the H.C. Wainwright 26áµ—Ê° Annual Global Investment Conference
PRINCETON, N.J., Aug. 27, 2024 ( GLOBE NEWSWIRE ) -- CytoSorbents Corporation ( NASDAQ: CTSO ) , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today announced ...
| Ticker |
Sentiment |
Impact |
|
META
|
Neutral
|
11 %
|
|
CTSO
|
Neutral
|
23 %
|
